Keyword Analysis & Research: oncolink aranesp
Keyword Research: People who searched oncolink aranesp also searched
Search Results related to oncolink aranesp on Search Engine
-
Darbepoetin Alfa (Aranesp®) | OncoLink
https://www.oncolink.org/cancer-treatment/oncolink-rx/darbepoetin-alfa-aranesp-r
Darbepoetin alfa is most often given as a subcutaneous injection (given under the skin), but can also be given intravenously (into a vein, or IV). The actual dose is based on your body size and will be determined by your healthcare provider. You may receive darbepoetin alfa at your treatment site or self … See more
DA: 14 PA: 57 MOZ Rank: 26
-
Oncolink
https://www.oncolink.org/
WebOncoLink, the Web's first cancer resource,provides comprehensive information on coping with cancer, cancer treatments, cancer research advances, continuing medical …
DA: 42 PA: 37 MOZ Rank: 40
-
OncoLink Rx | OncoLink
https://www.oncolink.org/cancer-treatment/oncolink-rx
WebOncoLink, the Web's first cancer resource,provides comprehensive information on coping with cancer, cancer treatments, ... Ara-C Aranesp® Aredia® Arimidex® Aromasin® …
DA: 100 PA: 92 MOZ Rank: 92
-
Aranesp® (darbepoetin alfa)
https://www.aranesp.com/.
WebAranesp ® is a prescription medicine used to treat a lower than normal number of red blood cells (anemia) caused by chronic kidney disease in patients on dialysis and not on … oncolink
oncolink
DA: 73 PA: 18 MOZ Rank: 69
-
Aranesp® (darbepoetin alfa) | Dosing Considerations
https://www.aranesp.com/professional/oncology/dosing
WebAranesp ® is the only long-acting erythropoiesis-stimulating agent (ESA) approved for both once weekly (QW) and once every three weeks (Q3W) dosing 1, 2. Aranesp ® dosing … oncolink
oncolink
DA: 71 PA: 21 MOZ Rank: 67
-
Resources - Aranesp
https://www.aranesp.com/patient/oncology/you
WebWhy might your oncologist prescribe Aranesp®?, If chemotherapy has caused you to develop anemia that cannot be managed with RBC transfusion, your healthcare provider may want to address your anemia … oncolink
oncolink
DA: 18 PA: 47 MOZ Rank: 8
-
HIGHLIGHTS OF PRESCRIBING INFORMATION
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103951s5377lbl.pdf
WebARANESP. ARANESP® (darbepoetin alfa) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2001. WARNING: ESAs INCREASE THE RISK OF DEATH, … oncolink
oncolink
DA: 49 PA: 91 MOZ Rank: 96
-
Aranesp® (darbepoetin alfa) | Role of APs
https://www.aranesp.com/professional/oncology/advanced_practitioners
WebUse the lowest Aranesp ® dose sufficient to reduce the need for red blood cell (RBC) transfusions. Cancer: ESAs shortened overall survival and/or increased the risk of tumor … oncolink
oncolink
DA: 48 PA: 79 MOZ Rank: 87
-
Frequently Asked Questions about Aranesp® …
https://news.cancerconnect.com/treatment-care/frequently-asked-questions-about-aranesp-darbepoetin-alfa
WebJul 9, 2019 · Treatment & Care. Generic Name: Darbepoetin Alfa (dar-be-POE-e-tin AL-fe) Trade Name: Aranesp®. For which conditions is Aranesp approved for? Aranesp® is approved for the treatment of anemia (low … oncolink
oncolink
DA: 42 PA: 72 MOZ Rank: 78
